ATE292978T1 - Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält - Google Patents

Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält

Info

Publication number
ATE292978T1
ATE292978T1 AT01958190T AT01958190T ATE292978T1 AT E292978 T1 ATE292978 T1 AT E292978T1 AT 01958190 T AT01958190 T AT 01958190T AT 01958190 T AT01958190 T AT 01958190T AT E292978 T1 ATE292978 T1 AT E292978T1
Authority
AT
Austria
Prior art keywords
nitrogen oxide
precursor
metabolism
composition containing
iron complexing
Prior art date
Application number
AT01958190T
Other languages
English (en)
Inventor
Bernard Dugas
Original Assignee
Isocell S A
Bernard Dugas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isocell S A, Bernard Dugas filed Critical Isocell S A
Application granted granted Critical
Publication of ATE292978T1 publication Critical patent/ATE292978T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT01958190T 2000-07-27 2001-07-27 Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält ATE292978T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009883A FR2812200B1 (fr) 2000-07-27 2000-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote ; et utilisations
PCT/FR2001/002469 WO2002009740A1 (fr) 2000-07-27 2001-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations

Publications (1)

Publication Number Publication Date
ATE292978T1 true ATE292978T1 (de) 2005-04-15

Family

ID=8852998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958190T ATE292978T1 (de) 2000-07-27 2001-07-27 Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält

Country Status (8)

Country Link
US (1) US6984624B2 (de)
EP (1) EP1303296B1 (de)
JP (1) JP2004520264A (de)
AT (1) ATE292978T1 (de)
AU (1) AU2001279922A1 (de)
DE (1) DE60110084D1 (de)
FR (1) FR2812200B1 (de)
WO (1) WO2002009740A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
DK1675501T3 (da) 2003-09-12 2013-11-18 Or Nim Medical Ltd Ikke-invasiv optisk monitorering af et område af interesse
ATE336695T1 (de) * 2004-04-23 2006-09-15 Abb Research Ltd Modell und regelung eines müllverbrennungsverfahrens
BRPI0515847A (pt) * 2004-10-08 2008-08-12 Unilever Nv uso de um complexo de ferro, composição alimentìcia, gênero alimentìcio fortificado com ferro, composição de bebida, bebida fortificada com ferro, suplemento alimentar e composição farmacêutica
US20090082305A1 (en) * 2005-03-30 2009-03-26 Kyowa Hakko Kogyo Co., Ltd. Method of improving storage stability of substance
WO2009102677A1 (en) * 2008-02-11 2009-08-20 Tabatchnick Fine Foods, Inc. A nutritionally enhanced therapeutic preventative food supplement and method of making same
WO2009101789A1 (ja) * 2008-02-14 2009-08-20 Morinaga Milk Industry Co., Ltd. 卵巣機能改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU704173B2 (en) * 1993-11-02 1999-04-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, The Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
US5827729A (en) * 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
JP2002515893A (ja) * 1997-02-03 2002-05-28 ファーミング インテレクチュアル プロパティ ビーブイ ヒトラクトフェリンおよびその改変体の有用な特性

Also Published As

Publication number Publication date
DE60110084D1 (de) 2005-05-19
US20040033945A1 (en) 2004-02-19
FR2812200B1 (fr) 2003-01-03
FR2812200A1 (fr) 2002-02-01
JP2004520264A (ja) 2004-07-08
US6984624B2 (en) 2006-01-10
AU2001279922A1 (en) 2002-02-13
EP1303296B1 (de) 2005-04-13
EP1303296A1 (de) 2003-04-23
WO2002009740A1 (fr) 2002-02-07

Similar Documents

Publication Publication Date Title
WO2007035757A3 (en) Composition and method for treating iron deficiency anemia
AU8188987A (en) Improved metal complex-containing pharmaceutical agents
NO20015991D0 (no) Bisykliske polyaminoacid-metallkomplekser, fremgangsmåter for fremstilling av disse og anvendelse i medisinsk billeddannelse
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
EP1311269A4 (de) Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten
UA34768A (uk) Склад для обробки пар тертя
NO954440D0 (no) 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler
WO1999059640A3 (en) Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
DE69717447D1 (de) Reduzierung der kardiotoxizität von antitumormitteln mit manganverbindungen
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
ATE143266T1 (de) Komplexe und chelate des azithromycins als antiulcus-mittel
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
DE60110084D1 (de) Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält
BR9912547A (pt) (poli)isocianatos ocultos mistos
CA2481593A1 (en) Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin
IL171875A0 (en) Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO1999011256A8 (en) L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
MXPA02005045A (es) Preparaciones farmaceuticas que contiene agentes citostaticos y aceptores de electrones para el tratamiento de cancer.
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
TW200637603A (en) Oral treatment compositions containing anti-adhesion agent, antibacterial agent and incompatible compound
WO2005039528A3 (de) Zusammensetzung zur arthrose-/arthritisbehandlung, insbesondere von gelenken
GR1004016B (el) Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων
DE60212424D1 (de) Radiopharmazeutishes mittel zur behandlung von krebs im frühstadium

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties